Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1122304
PUBLISHER: Grand View Research | PRODUCT CODE: 1122304
Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (IUDs, Pills, Implants), By Hormone (Combination Hormonal Contraceptives, Progestin-only), By Region, And Segment Forecasts, 2022 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Hormonal Contraceptive Market Growth & Trends:
The global hormonal contraceptive market size is expected to reach USD 24.2 billion by 2030, based on a new report by Grand View Research, Inc. It is projected to register a CAGR of 4.29% during the forecast period. The introduction of innovative products and growing awareness about reproductive & sexual health in emerging regions are likely to drive the growth. An increasing number of women in developing economies are using contraceptives due to the rise in government initiatives and programs. This factor is anticipated to accelerate market growth. For instance, according to the UN World Fertility and Family Planning 2020, in 2019, 49% of the women of reproductive age received some form of contraception to avoid pregnancy with 91% of women among them using modern contraceptive methods including implants, patches, IUDs, and others.
According to the State of World Population 2022, by UNFPO, globally, approximately 50% of all 121 million pregnancies each year are unwanted. As per the Seeing, the Unseen: The case for action in the neglected crisis of unintended pregnancy, more than 60% of unwanted pregnancies result in abortion and the projected 45% among them are unsafe. Hence, to avoid unsafe abortions, countries are spreading awareness about contraceptives, which is expected to propel industry growth. The IUD segment is expected to witness the fastest growth during the forecast period due to the entry of new devices, the availability of long-acting reversible birth control methods, and more than 99.0% effectiveness.
The COVID-19 pandemic has significantly impacted the industry owing to supply chain disruptions and a decline in family planning numbers. Contraceptive manufacturers, such as Merck & Co., have reported reduced demand for the contraceptive implant, Nexplanon, due to the prioritization of COVID-19 patients by healthcare providers. The industry is fragmented owing to the introduction of various generic drugs. For instance, in December 2019, Prasco, in collaboration with Merck & Co., Inc., launched the generic version of the NuvaRing, a vaginal ring containing ethinylestradiol.
Hormonal Contraceptive Market Report Highlights:
- High demand for contraceptive methods can be attributed to the rising awareness about pills & devices, the significance of family planning, and the presence of supportive government policies improving access to these products
- By hormone, the combination hormonal contraceptive segment held the largest share in 2021 owing to the fewer side effects and lower chances of developing acne and related symptoms
- Based on method, pills accounted for the largest share in 2021 as these products are convenient to use and exhibit more than 99.0% effectivity when accurately consumed
- Furthermore, the ease of availability, fewer adverse effects, and the presence of a large number of players contribute to the segment growth
- North America held the largest share in 2021 and is anticipated to maintain its dominance during the forecast period due to the presence of major market players, high per capita income, and supportive government initiatives
- The Asia Pacific is estimated to witness the fastest CAGR from 2022 to 2030 due to high unmet needs, an expected increase in coverage in the next 15 years, and an increasing number of women in their reproductive age
Product Code: GVR-2-68038-348-5
Table of Contents
Chapter 1 Report Scope and Objectives
- 1.1 Market Segmentation
- 1.2 Regional Scope
- 1.3 Estimates and Forecast Timeline
- 1.4 Research Objectives
- 1.4.1 Objective - 1
- 1.4.2 Objective - 2
- 1.4.3 Objective - 3
Chapter 2 Methodology
- 2.1 Research Methodology
- 2.1.1 Information procurement
- 2.1.2 Purchased Database
- 2.1.3 GVR's Internal Database
- 2.1.4 Secondary Sources
- 2.1.5 Primary Research
- 2.2 Information or Data Analysis
- 2.2.1 Data Analysis Models
- 2.3 Market Formulation & Validation
- 2.4 Model Details
- 2.4.1 Commodity Flow Analysis
- 2.4.2 Volume price analysis
- 2.5 List of Secondary Sources
- 2.6 List of Abbreviations
Chapter 3 Executive Summary
- 3.1 Market Outlook
- 3.2 Segment Outlook
- 3.2.1 Hormone
- 3.2.2 Method
- 3.3 Regional Outlook
- 3.4 Competitive Insights
Chapter 4 Market Variables, Trends & Scope
- 4.1 Market Lineage Outlook
- 4.1.1 Parent Market Outlook
- 4.1.2 Related/Ancillary Market Outlook
- 4.2 Hormonal Contraceptive Market Dynamics
- 4.2.1 Market Driver Analysis
- 4.2.1.1 Rise in government and NGO initiatives to promote contraceptive methods
- 4.2.1.2 High unmet needs
- 4.2.2 Market Restraint Analysis
- 4.2.2.1 Rapidly aging population and rising prevalence of infertility
- 4.2.2.2 Adverse effects associated with the use of contraceptive drugs and devices
- 4.2.1 Market Driver Analysis
- 4.3 Hormonal Contraceptive Market: Business Environment Analysis Tools
- 4.3.1 Porter's five forces analysis
- 4.3.2 PESTLE Analysis
- 4.3.2.1 Political & legal
- 4.3.2.2 Economic & Social
- 4.3.2.3 Technological
- 4.4 Penetration & Growth Prospect Mapping
- 4.5 Qualitative Analysis: Impact of COVID-19 on the Hormonal Contraceptive Market
Chapter 5 Hormonal Contraceptive Market: Hormone Analysis
- 5.1 Hormonal Contraceptive Hormone Market Share Analysis, 2021 & 2030
- 5.2 Hormonal Contraceptive Hormone Market: Segment Dashboard
- 5.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Hormone Segment
- 5.3.1 Combination Hormonal Contraceptives
- 5.3.1.1 Combination hormonal contraceptives market, 2017 - 2030 (USD Million)
- 5.3.2 Progestin-only
- 5.3.2.1 Progestin-only market, 2017 - 2030 (USD Million)
- 5.3.1 Combination Hormonal Contraceptives
Chapter 6 Hormonal Contraceptive Market: Method Analysis
- 6.1 Hormonal Contraceptive Method Market Share Analysis, 2021 & 2030
- 6.2 Hormonal Contraceptive Method Market: Segment Dashboard
- 6.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Method Segment
- 6.3.1 Pills
- 6.3.1.1 Pills market, 2017 - 2030 (USD Million)
- 6.3.2 Intrauterine Devices (IUD)
- 6.3.2.1 Intrauterine Devices (IUD) market, 2017 - 2030 (USD Million)
- 6.3.3 Injectable
- 6.3.3.1 Injectable market, 2017 - 2030 (USD Million)
- 6.3.4 Vaginal Ring
- 6.3.4.1 Vaginal Ring market, 2017 - 2030 (USD Million)
- 6.3.5 Implant
- 6.3.5.1 Implant market, 2017 - 2030 (USD Million)
- 6.3.6 Patch
- 6.3.6.1 Patch market, 2017 - 2030 (USD Million)
- 6.3.1 Pills
Chapter 7 Hormonal Contraceptive Market: Regional Analysis
- 7.1 Hormonal Contraceptive Regional Market Share Analysis, 2020 & 2030
- 7.2 Regional Market Snapshot
- 7.3 Market Size, & Forecasts and Trend Analysis, 2017 to 2030
- 7.3.1 North America
- 7.3.1.1 North America Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.1.2 U.S.
- 7.3.1.2.1 U.S. Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.1.3 Canada
- 7.3.1.3.1 Canada Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.2 Europe
- 7.3.2.1 Europe Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.2.2 U.K.
- 7.3.2.2.1 U.K. Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.2.3 Germany
- 7.3.2.3.1 Germany Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.2.4 France
- 7.3.2.4.1 France Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.2.5 Italy
- 7.3.2.5.1 Italy Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.2.6 Spain
- 7.3.2.5.1 Spain Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.3 Asia Pacific
- 7.3.3.1 Asia Pacific Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.3.2 Japan
- 7.3.3.2.1 Japan Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.3.3 China
- 7.3.3.3.1 China Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.3.4 India
- 7.3.3.4.1 India Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.3.5 Australia
- 7.3.3.5.1 Australia Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.3.6 South Korea
- 7.3.3.6.1 South Korea Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.4 Latin America
- 7.3.4.1 Latin America Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.4.2 Mexico
- 7.3.4.2.1 Mexico Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.4.3 Brazil
- 7.3.4.3.1 Brazil Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.4.4 Argentina
- 7.3.4.4.1 Argentina Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.5 Middle East & Africa
- 7.3.5.1 Middle East & Africa Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.5.2 South Africa
- 7.3.5.2.1 South Africa Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.5.2 Saudi Arabia
- 7.3.5.2.1 Saudi Arabia Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.5.3 UAE
- 7.3.5.3.1 UAE Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
- 7.3.1 North America
Chapter 8 Competitive Analysis
- 8.1 Recent Developments & Impact Analysis, by Key Market Participants
- 8.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
- 8.3 Company Market Position Analysis
- 8.4 Company Profiles
- 8.4.1 ABBVIE INC.
- 8.4.1.1 Company overview
- 8.4.1.2 Financial performance
- 8.4.1.3 Product benchmarking
- 8.4.1.4 Strategic initiatives
- 8.4.2 BAYER AG
- 8.4.2.1 Company overview
- 8.4.2.2 Financial performance
- 8.4.2.3 Product benchmarking
- 8.4.2.4 Strategic initiatives
- 8.4.3 Organon group of companies.
- 8.4.3.1 Company overview
- 8.4.3.2 Financial performance
- 8.4.3.3 Product benchmarking
- 8.4.3.4 Strategic initiatives
- 8.4.4 PFIZER
- 8.4.4.1 Company overview
- 8.4.4.2 Financial performance
- 8.4.4.3 Product benchmarking
- 8.4.5 AFAXYS, INC.
- 8.4.5.1 Company overview
- 8.4.5.2 Financial performance
- 8.4.5.3 Product benchmarking
- 8.4.5.4 Strategic initiatives
- 8.4.6 TEVA PHARMACEUTICAL INDUSTRIES LTD
- 8.4.6.1 Company overview
- 8.4.6.2 Financial performance
- 8.4.6.3 Product benchmarking
- 8.4.6.4 Strategic initiatives
- 8.4.7 AGILE THERAPEUTICS
- 8.4.7.1 Company overview
- 8.4.7.2 Financial performance
- 8.4.7.3 Product benchmarking
- 8.4.7.4 Strategic initiatives
- 8.4.8 JANSSEN PHARMACEUTICALS, INC.
- 8.4.8.1 Company overview
- 8.4.8.2 Financial performance
- 8.4.8.3 Product benchmarking
- 8.4.8.4 Strategic initiatives
- 8.4.9 Lupin Pharmaceuticals, Inc.
- 8.4.9.1 Company overview
- 8.4.9.2 Financial performance
- 8.4.9.3 Product benchmarking
- 8.4.9.4 Strategic initiatives
- 8.4.10 Pregna International Limited.
- 8.4.10.1 Company overview
- 8.4.10.2 Financial performance
- 8.4.10.3 Product benchmarking
- 8.4.10.4 Strategic initiatives
- 8.4.1 ABBVIE INC.
Product Code: GVR-2-68038-348-5
List of Tables
- TABLE 1 List of secondary sources
- TABLE 2 List of abbreviations
- TABLE 3 Global hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 4 Global hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 5 North America hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
- TABLE 6 North America hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 7 North America hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 8 U.S. hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 9 U.S. hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 10 Canada hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 11 Canada hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 12 Europe hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
- TABLE 13 Europe hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 14 Europe hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 15 Germany hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 16 Germany hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 17 U.K. hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 18 U.K. hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 19 France hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 20 France hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 21 Italy hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 22 Italy hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 23 Spain hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 24 Spain hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 25 Asia Pacific hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
- TABLE 26 Asia Pacific hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 27 Asia Pacific hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 28 Japan hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 29 Japan hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 30 China hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 31 China hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 32 India hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 33 India hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 34 Australia hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 35 Australia hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 36 South Korea hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 37 South Korea hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 38 Latin America hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
- TABLE 39 Latin America hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 40 Latin America hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 41 Brazil hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 42 Brazil hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 43 Mexico hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 44 Mexico hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 45 Argentina hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 46 Argentina hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 47 Middle East & Africa (MEA) hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
- TABLE 48 Middle East & Africa (MEA) hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 49 Middle East & Africa (MEA) hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 50 South Africa hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 51 South Africa hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 52 Saudi Arabia hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 53 Saudi Arabia hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
- TABLE 54 UAE hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
- TABLE 55 UAE hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
List of Figures
- FIG. 1 Hormonal contraceptives market segmentation
- FIG. 2 Market research process
- FIG. 3 Information procurement
- FIG. 4 Primary research pattern
- FIG. 5 Market research approaches
- FIG. 6 Value chain-based sizing & forecasting
- FIG. 7 QFD modeling for market share assessment
- FIG. 8 Market formulation & validation
- FIG. 9 Hormonal contraceptive market outlook, 2021
- FIG. 10 Hormonal contraceptive market trends & outlook
- FIG. 11 Market driver relevance analysis (Current & future impact)
- FIG. 12 Market restraint relevance analysis (Current & future impact)
- FIG. 13 Penetration & growth prospect mapping
- FIG. 14 Hormonal contraceptives market: Hormone movement analysis (USD Million)
- FIG. 15 Hormonal contraceptives market hormone outlook: Key takeaways (USD Million)
- FIG. 16 Combination hormonal contraceptives market, 2017 - 2030 (USD Million)
- FIG. 17 Progestin-only market, 2017 - 2030 (USD Million)
- FIG. 19 Pill market, 2017 - 2030 (USD Million)
- FIG. 20 Hormonal contraceptives market: Method movement analysis (USD Million)
- FIG. 21 Hormonal contraceptives market method outlook: Key takeaways (USD Million)
- FIG. 22 Intrauterine device market, 2017 - 2030 (USD Million)
- FIG. 23 Injectable market, 2017 - 2030 (USD Million)
- FIG. 24 Vaginal ring market, 2017 - 2030 (USD Million)
- FIG. 25 Implant market, 2017 - 2030 (USD Million)
- FIG. 26 Patch market, 2017 - 2030 (USD Million)
- FIG. 27 Regional outlook, 2021 & 2030
- FIG. 28 Regional marketplace: Key takeaways
- FIG. 29 North America hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 30 U.S. hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 31 Canada hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 32 Europe hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 33 U.K. hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 34 Germany hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 35 France hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 36 Italy hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 37 Spain hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 38 Asia Pacific hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 39 Japan hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 40 China hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 41 Australia hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 42 South Korea hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 43 Latin America hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 44 Brazil hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 45 Mexico hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 46 Argentina hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 47 MEA hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 48 South Africa hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 49 Saudi Arabia hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 50 UAE hormonal contraceptive market, 2017 - 2030 (USD Million)
- FIG. 51 Recent developments and impact analysis
- FIG. 52 Company categorization
- FIG. 53 Company market position analysis
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.